KOSDAQ · Healthcare · ₩103B
₩5,110+0.79%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.8% · as of 26.10.27
Among 15 신약 개발 peers
Quarterly Revenue Growth
“치료 성과가 실제 판매로 이어질 준비를 시작했어요.”
In the company's words · 2026 2분기 filing